Drugs / autologous idiotype-protein pulsed dendritic cells
autologous idiotype-protein pulsed dendritic cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00988312 | Mar 2002 → Feb 2004 | plasma cell myeloma, plasmacytoma | University Hospital Carl Gustav Carus | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous idiotype-protein pulsed dendritic cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00988312 ↗ |
| Modality | Vaccine | “Patients with stage-I multiple myeloma are treated with a vaccine made from their own immune cells (dendritic cells) and their own myeloma protein.” NCT00988312 ↗ |
| Route | Subcutaneous | “vaccine given subcutaneously” NCT00988312 ↗ |